Jade Dennis is a clinical development innovation and patient engagement leader with extensive experience in global and Asia Pacific clinical research across Phase I-IV trials in the Pharma/Biotech sectors. Currently serving as the Executive Director of Clinical Trial Design Capabilities at Eli Lilly and Company, Jade incorporates AI, analytics, real-world data, and patient and HCP input into clinical development processes. Previously, Jade held pivotal roles at organizations such as Virocure, Odonate Therapeutics™, and Eli Lilly, where they excelled in project management and strategic leadership, driving optimization of study designs and clinical strategies. Jade earned a Bachelor of Biomedical Science with Honours from the University of Newcastle, where they received the University Medal.
This person is not in the org chart
This person is not in any teams
This person is not in any offices